Linden Advisors’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Linden Advisors’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-44,932	Closed	-$462K	–	536
2022 Q4	$462K	Hold	44,932	–	–	﹤0.01%	343
2022 Q3	$452K	Hold	44,932	–	–	﹤0.01%	430
2022 Q2	$450K	Sell	44,932 -655,068	-94%	-$6.55M	﹤0.01%	461
2022 Q1	$7M	Buy	+700,000	New	+$6.95M	0.04%	265

Other funds holding IQMD

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Linden Advisors's IQMD Position: Q1 2023 in Review

Linden Advisors sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 44,932 shares — an estimated $462K sold.

Linden Advisors first reported a position in IQMD in Q1 2022 and held it in 4 quarters. The position peaked at $7M in Q1 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

Linden Advisors reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Linden Advisors sold 44,932 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $462K.
Linden Advisors first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 4 quarters.
Linden Advisors's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $7M in Q1 2022.
8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Linden Advisors's 13F filing for Q1 2023, filed 15 May 2023.